Christopher M. Starr, Director at Raptor Pharmaceutical Corp (RPTP), sold 30,000 shares at $9.45 ($284K) on 2015-01-22, disclosed to the SEC on 2015-01-26.
Scheduled sale ($284k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RPTP | SELL | 2015-03-18 | $352K | — | Filing → |
| RPTP | SELL | 2015-02-25 | $286K | — | Filing → |
| RPTP | SELL | 2015-02-19 | $281K | — | Filing → |